Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

The purpose of these studies was to determine whether systemic administration of IFN-alpha can inhibit the expression of basic fibroblast growth factor (bFGF) in human transitional cell carcinoma, reduce its angiogenesis, and thus inhibit its growth in the bladder wall of nude mice. In vitro incubation of the highly metastatic 253J B-V cells and the IFN-alpha-resistant 253J B-V IFNR cells with noncytostatic concentrations of IFN-alpha down-regulated the steady-state mRNA transcripts and protein production of bFGF. IFN-alpha-insensitive and IFN-alpha-resistant cells were implanted in the bladder wall of nude mice. Systemic administration of IFN-alpha decreased the in vivo expression of bFGF, decreased blood vessel density in the tumors, and inhibited tumor growth of both IFN-alpha-insensitive and IFN-alpha-resistant cells. These data suggest that in addition to its well-documented antiproliferative effects, IFN-alpha can inhibit the growth of human bladder cancer cells by inhibition of angiogenesis.

[1]  A. Kramer,et al.  Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytoma. , 1996, Journal of the National Cancer Institute.

[2]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[3]  S. Groshen,et al.  Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. , 1995, Journal of the National Cancer Institute.

[4]  C. Bucana,et al.  Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. , 1995, The Journal of urology.

[5]  C. Bucana,et al.  Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Ellis,et al.  In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. , 1995, The American journal of pathology.

[7]  R. Figlin,et al.  In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin‐2 and/or interferon‐alpha gene transfer , 1994, Cancer.

[8]  C. Bucana,et al.  Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. , 1994, The American journal of pathology.

[9]  S. Kosak,et al.  Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade. , 1994, Leukemia research.

[10]  C. Garlanda,et al.  Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. , 1994, European journal of cell biology.

[11]  J. Richie,et al.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. , 1994, Journal of the National Cancer Institute.

[12]  J U Gutterman,et al.  Cytokine therapeutics: lessons from interferon alpha. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Bucana,et al.  Regulation of Gelatinase Production in Metastatic Renal Cell Carcinoma by Organ‐specific Fibroblasts , 1994, Japanese journal of cancer research : Gann.

[14]  C. Bucana,et al.  A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  L. Ellis,et al.  A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. , 1993, Cancer research.

[16]  C. Dinney,et al.  The importance of orthotopic implantation to the isolation and biological characterization of a metastatic human clear cell renal-carcinoma in nude-mice. , 1993, International journal of oncology.

[17]  C. Bucana,et al.  Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. , 1992, Differentiation; research in biological diversity.

[18]  J. Mulliken,et al.  Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy , 1992, The New England journal of medicine.

[19]  F. Dianzani,et al.  Interferon treatments: how to use an endogenous system as a therapeutic agent. , 1992, Journal of interferon research.

[20]  J. Folkman,et al.  The role of angiogenesis in tumor growth. , 1992, Seminars in cancer biology.

[21]  K. Öberg.  The action of interferon alpha on human carcinoid tumours. , 1992 .

[22]  K. Oberg.  The action of interferon alpha on human carcinoid tumours. , 1992, Seminars in cancer biology.

[23]  S. Baron,et al.  The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.

[24]  J. Sinkovics.  Kaposi's sarcoma: its 'oncogenes' and growth factors. , 1991, Critical reviews in oncology/hematology.

[25]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[26]  V. Srikantan,et al.  Differential effects of interferon gamma and alpha on in vitro model of angiogenesis , 1991, Journal of cellular physiology.

[27]  R. Florkiewicz,et al.  Functional characterization of the human basic fibroblast growth factor gene promoter. , 1991, Growth factors.

[28]  F. Balkwill.  Cytokines in Cancer Therapy , 1989 .

[29]  H. Dvorak,et al.  Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. , 1989, Journal of the National Cancer Institute.

[30]  I. Fidler,et al.  Clonal stimulation or inhibition of human colon carcinomas and human renal carcinomas mediated by transforming growth factor-beta 1. , 1989, Cancer communications.

[31]  H. Koeppen,et al.  Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. , 1988, Cancer research.

[32]  R. Weinberg,et al.  Basic fibroblast growth factor fused to a signal peptide transforms cells , 1988, Nature.

[33]  E. Borden,et al.  Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. , 1987, Cancer research.

[34]  I. Fidler,et al.  Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice. , 1986, Cancer research.

[35]  C. Dani,et al.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. , 1985, Nucleic acids research.

[36]  A. Kimchi,et al.  Close link between reduction of c-myc expression by interferon and G0/G1 arrest , 1985, Nature.

[37]  E. Antón,et al.  Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Darnell,et al.  Transcriptional induction of two genes in human cells by beta interferon. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Stark,et al.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells , 1984, Cell.

[40]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[41]  J. Folkman.  Angiogenesis: initiation and modulation. , 1983, Symposium on Fundamental Cancer Research.

[42]  B. Zetter,et al.  Inhibition of cell motility by interferon. , 1980, Science.

[43]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[44]  I. Gresser.  Antitumor effects of interferon. , 1978, Advances in cancer research.